Literature DB >> 12788957

Recent developments in the treatment of alcoholic hepatitis.

R Madhotra1, I T Gilmore.   

Abstract

Alcoholic hepatitis is a form of acute injury to liver tissue that is also a precursor of cirrhosis, and carries significant morbidity and mortality. Severe alcoholic hepatitis in particular carries a high short-term mortality, and also places an enormous burden on stretched healthcare resources. Treatment of alcoholic hepatitis has been limited to supportive management and nutritional supplementation without clear improvements in outcome, and the timing and patient selection for hepatic transplantation is problematic. The use of corticosteroids has remained controversial for many years, but probably has a role in selected patients. Various other therapeutic strategies have been tested over the decades and none has shown any consistent benefit. Recently there have been major developments in our understanding of the mechanisms of alcoholic liver injury, including the role of cytokines and hepatocyte apoptosis. For the first time, there are exciting possibilities for specific therapies for this challenging and serious condition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788957     DOI: 10.1093/qjmed/hcg076

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  3 in total

1.  Improvement of liver function by the administration of oyster extract as a dietary supplement to habitual alcohol drinkers: A pilot study.

Authors:  Kenji Osaki; Yoshio Shimizu; Tetsuro Yamamoto; Fumiharu Miyake; Sumio Kondo; Hideyo Yamaguchi
Journal:  Exp Ther Med       Date:  2015-06-10       Impact factor: 2.447

2.  FR167653 attenuates murine immunological liver injury.

Authors:  Hong-Wei Yao; Jun Li; Ji-Qiang Chen
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

Review 3.  Pentoxifylline for alcoholic hepatitis.

Authors:  Kate Whitfield; Andrea Rambaldi; Jørn Wetterslev; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.